Shares of other companies:
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
April 12, 2024 Banks Brace for Earnings Amid Rate Cut Speculations
April 8, 2024 Robotaxi Revolution: Hype or Reality?
Apple’s Technical Climb To $240 By Year-End
April 15, 2024
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
ECOR Stock News and Mentions of electroCore, Inc. Stocktwits
Updated: April 18, 2024 (09:14)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where electroCore Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of electroCore, Inc. (ECOR).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the electroCore stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of electroCore, Inc. (ECOR)
April 8, 2024 (12:30) / "Benzinga" (by Globe Newswire)
electroCore Announces the Launch of Truvaga Plus® for General Wellness - electroCore ( NASDAQ:ECOR )
ROCKAWAY, N.J., April 08, 2024 ( GLOBE NEWSWIRE ) -- electroCore, Inc. ECOR, a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its direct-to-consumer mobile app-enabled product for general wellness, Truvaga Plus, which will be available on ...
In Article Trend: Bullish
April 2, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Electroceuticals/Bioelectric Medicine Market is Expected to Reach $33.6 billion | MarketsandMarkets™
Chicago, April 02, 2024 ( GLOBE NEWSWIRE ) -- Electroceuticals/Bioelectric Medicine market in terms of revenue was estimated to be worth $23.9 billion in 2024 and is poised to reach $33.6 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2029 according to a latest report published by ...
In Article Trend: Somewhat-Bullish
March 13, 2024 (21:25) / "Zacks Commentary" (by Zacks Equity Research)
ElectroCore, Inc. ( ECOR ) Reports Q4 Loss, Lags Revenue Estimates
electroCore, Inc. (ECOR) delivered earnings and revenue surprises of -10.91% and 0.65%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Neutral
March 13, 2024 (20:05) / "GlobeNewswire" (by Inc.)
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year ...
In Article Trend: Neutral
March 13, 2024 (20:05) / "Benzinga" (by Globe Newswire)
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results - electroCore ( NASDAQ:ECOR )
Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2022 Company to host conference call and webcast today, March 13, 2024 at 4:30pm EST ROCKAWAY, N.J., March 13, 2024 ( GLOBE NEWSWIRE ) -- electroCore, Inc.
In Article Trend: Neutral
March 12, 2024 (12:00) / "GlobeNewswire" (by electroCore)
electroCore to Participate in Upcoming Investor Conferences
ROCKAWAY, N.J., March 12, 2024 ( GLOBE NEWSWIRE ) -- electroCore, Inc. ( Nasdaq: ECOR ) , a commercial-stage bioelectronic medicine and wellness company, announced today that the Company's Chief Strategy Officer, Joshua Lev, is scheduled to attend the 36th Annual Roth Conference taking place at ...
In Article Trend: Somewhat-Bullish
March 6, 2024 (13:15) / "Zacks Commentary" (by Zacks Equity Research)
Xeris Biopharma ( XERS ) Reports Q4 Loss, Lags Revenue Estimates
Xeris Biopharma (XERS) delivered earnings and revenue surprises of -11.11% and 2.44%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Neutral
February 26, 2024 (22:20) / "Zacks Commentary" (by Zacks Equity Research)
Revolution Medicines, Inc. ( RVMD ) Reports Q4 Loss, Lags Revenue Estimates
Revolution Medicines, Inc. (RVMD) delivered earnings and revenue surprises of -32.56% and 87.63%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Neutral
February 22, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Neuromodulation Market is Expected to Reach $11.0 Billion | MarketsandMarkets™
Chicago, Feb. 22, 2024 ( GLOBE NEWSWIRE ) -- Neuromodulation market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at a CAGR of 12.0% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website